デジタル病理の市場規模、シェア、成長分析：製品別、タイプ別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

世界のデジタル病理の市場規模は、2022年に10億5,159万米ドルとなり、予測期間（2024年～2031年）のCAGRは7.8%で、2023年の11億3,361万米ドルから、2031年までには20億6,736万米ドルに成長する見通しです。

デジタル病理の世界市場は、より正確で効率的な診断ツールへのニーズの高まりにより、医療診断および研究分野で急速な拡大が見られます。デジタル病理は病理標本のデジタルフォーマットへの変換と分析を行い、病理医間の共同作業を容易にし、より正確な診断と迅速な納期を実現します。この市場を推進している主要な要因は、個別化医療に対する需要の高まりであり、より正確で的を絞った診断アプローチが必要とされています。さらに、がんやその他の慢性疾患の有病率の増加が、高度な診断ツールの必要性を煽っています。人工知能（AI）と機械学習がデジタル病理に統合されることで、診断の精度と効率が向上し、市場の成長がさらに促進されると期待されています。しかし、デジタル病理システムの高コストや熟練オペレーターの必要性などの課題に直面しており、特に新興国市場での導入が制限される可能性があります。また、データのプライバシーやセキュリティに関する懸念も、市場成長の潜在的な障害となっています。このような課題にもかかわらず、市場には革新と開拓の大きなチャンスがあります。デジタル病理を遠隔医療やクラウドコンピューティングなどの技術と統合することで、共同作業や効率向上の新たな可能性が開けます。また、遠隔病理診断やデジタル病理プラットフォームの研究・学術現場での利用が増加していることも、市場拡大の新たな機会を生み出しています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主要な市場の考察

• 市場の主要な成功要因
• 競合の程度
• 主要な投資機会
• 市場魅力度指数
• エコシステムマッピング
• 市場需要分析
• テクノロジーとイノベーションの分析
• 費用便益分析
• 競合情勢分析
• 市場の成長と機会の分析
• 将来の市場分析

デジタル病理市場：製品別

• 市場概要
• ソフトウェア
  • タイプ別
    • 統合型
    • スタンドアロン
  • 展開モデル別
    • オンプレミス
    • クラウドベース
  • スキャナー
    • 明視野
    • その他
  • デバイス
  • ストレージシステム

デジタル病理市場：用途別

• 市場概要
• 創薬・開発
• 学術研究
• 疾患診断

デジタル病理市場：タイプ別

• 市場概要
• 人間病理学
• 獣医病理学

デジタル病理市場：最終用途別

• 市場概要
• 製薬
• バイオテクノロジー

デジタル病理市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Philips Healthcare（Netherlands）
• Roche Diagnostics（Switzerland）
• Hamamatsu Photonics（Japan）
• 3DHISTECH（Hungary）
• GE Healthcare（US）
• Apollo Enterprise Imaging（US）
• Olympus Corporation（Japan）
• Mikroscan Technologies（US）
• Inspirata（US）
• PerkinElmer（US）
• Huron Digital Pathology（Canada）
• Sectra AB（Sweden）
• PathAI（US）
• Indica Labs（US）
• F. Hoffmann-La Roche（Switzerland）
• Nikon Corporation（Japan）
• Danaher Corporation（US）
• Visiopharm（Denmark）
• Densitas（Canada）
• Objective Pathology（US）
• QPath（US）

Global Digital Pathology Market size was valued at USD 1051.59 million in 2022 and is poised to grow from USD 1133.61 million in 2023 to USD 2067.36 million by 2031, at a CAGR of 7.8% during the forecast period (2024-2031).

The global digital pathology market is experiencing rapid expansion within the medical diagnostics and research fields, driven by the rising need for more accurate and efficient diagnostic tools. Digital pathology involves the conversion and analysis of pathology specimens into digital formats, facilitating easier collaboration among pathologists, more precise diagnoses, and quicker turnaround times. A major factor propelling this market is the increasing demand for personalized medicine, which necessitates more precise and targeted diagnostic approaches. Additionally, the growing prevalence of cancer and other chronic conditions fuels the need for advanced diagnostic tools. The integration of artificial intelligence (AI) and machine learning into digital pathology is expected to further drive market growth by improving diagnostic accuracy and efficiency. However, the market faces challenges, including the high cost of digital pathology systems and the need for skilled operators, which may restrict adoption, especially in developing regions. Data privacy and security concerns also present potential obstacles to market growth. Despite these challenges, the market offers substantial opportunities for innovation and development. The integration of digital pathology with technologies such as telemedicine and cloud computing opens up new possibilities for collaboration and enhanced efficiency. The increasing use of remote pathology consultations and digital pathology platforms in research and academic settings also creates additional opportunities for market advancement.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Pathology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Pathology Market Segmental Analysis

Global Digital Pathology Market is segmented based on product, application, and region. Based on product, the market is segmented into Software {by type [integrated and standalone (information management system and image analysis software)], by deployment mode (on premises and cloud based), scanners (brightfield scanners and other scanners), device, and storage systems. By application, the market is segmented into drug discovery & development, academic research, and disease diagnosis. By type, the market is segmented into human pathology and veterinary pathology. By end use it is segmented into pharmaceutical and biotechnology, Hospitals & Reference Laboratories, Academic & Research Institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Digital Pathology Market

Ongoing advancements in digital imaging technology, including whole-slide imaging (WSI), high-resolution scanners, and sophisticated image analysis software, are significantly boosting the adoption of digital pathology. These technological improvements provide enhanced image quality, quicker scanning speeds, and advanced analytical capabilities, leading to more precise and efficient diagnoses. For instance, the integration of deep learning algorithms and artificial intelligence (AI) tools has enabled automated image analysis, allowing for the detection of abnormalities in pathology slides. This supports pathologists by streamlining their decision-making processes and improving diagnostic accuracy.

Restraints in the Global Digital Pathology Market

Implementing digital pathology systems involves considerable initial investment in equipment such as scanners, storage infrastructure, and software solutions. The expenses associated with digitizing slides, maintaining digital archives, and training staff can be significant, especially for smaller laboratories or healthcare facilities with constrained budgets. Moreover, integrating digital pathology into existing laboratory workflows, along with the requirements for IT support and infrastructure upgrades, can present challenges for some organizations.

Market Trends of the Global Digital Pathology Market

The growing adoption of telepathology is enhancing the ability to conduct remote diagnoses and consultations, allowing pathologists to collaborate and offer expert opinions without geographical limitations. This technology has become increasingly important during the COVID-19 pandemic, as it supports remote work and reduces the risk of exposure for pathologists. For instance, pathologists can review and discuss cases with colleagues from afar, engage in multidisciplinary tumor board meetings, or offer consultations to underserved regions facing a shortage of pathology expertise.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors of The Market
• Degree Of Competition
• Top Investment Pockets
• Market Attractive Index
• Ecosystem Mapping
• Market demand analysis
• Technology and Innovation Analysis
• Cost Benefit Analysis
• Competitive Landscape Analysis
• Market Growth and Opportunity Analysis
• Future Market Analysis

Global Digital Pathology Market by product

• Market Overview
• Software
  • By Type
    • integrated
    • standalone
  • By Deployment Model
    • On Premises
    • Cloud Based
  • Scanner
    • Brightfield
    • Other
  • Device
  • Storage system

Global Digital Pathology Market by Application

• Market Overview
• Drug discovery and development
• Academic research
• Disease diagnosis

Global Digital Pathology Market by Type

• Market Overview
• Human pathology
• Veterinary pathology

Global Digital Pathology Market by End Use

• Market Overview
• Pharmaceutical
• Biotechnology

Global Digital Pathology Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Philips Healthcare (Netherlands)
• Roche Diagnostics (Switzerland)
• Hamamatsu Photonics (Japan)
• 3DHISTECH (Hungary)
• GE Healthcare (US)
• Apollo Enterprise Imaging (US)
• Olympus Corporation (Japan)
• Mikroscan Technologies (US)
• Inspirata (US)
• PerkinElmer (US)
• Huron Digital Pathology (Canada)
• Sectra AB (Sweden)
• PathAI (US)
• Indica Labs (US)
• F. Hoffmann-La Roche (Switzerland)
• Nikon Corporation (Japan)
• Danaher Corporation (US)
• Visiopharm (Denmark)
• Densitas (Canada)
• Objective Pathology (US)
• QPath (US)